Hyliion HYLN
$1.83 −$0.18 (-8.96%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $1.86 +1.64%
Open$2.01
Prev close$2.01
Day range$1.81 – $2.01
Volume3.06M
Market cap$327.43M
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$7.45M+881.8% YoY
Operating profit-$12.44M+19.1% YoY
Net profit-$11.06M+17.0% YoY
Diluted EPS-$0.06+25.0% YoY
Free cash flow-$10.75M+49.1% YoY
Operating cash flow-$10.46M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin7.5%
Operating margin-357.9%
Net margin-313.1%
Return on equity-27.4%
Return on assets-25.4%
Return on invested capital-29.6%
Current ratio7.79
Liabilities / assets9.2%
Cash & investments$54.62M
Total debt$7.17M
Net cash (debt)$47.45M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $7.45M | $4.94M | $2.83M | $3.48M | $712,000.00 |
| Total Operating Revenue | $7.45M | $4.94M | $2.83M | $3.48M | $712,000.00 |
| Cost of Revenue | $6.90M | $4.58M | $2.62M | $3.31M | $638,000.00 |
| Gross Profit | $552,000.00 | $366,000.00 | $210,000.00 | $170,000.00 | $74,000.00 |
| Operating Expense | $12.99M | $15.92M | $13.85M | $65.22M | $15.49M |
| Selling and Admin Expenses | $4.29M | $6.43M | $6.18M | $22.76M | $5.53M |
| Research & Development | $8.70M | $9.50M | $7.67M | $42.47M | $9.96M |
| Operating Profit | -$12.44M | -$15.56M | -$13.64M | -$65.05M | -$15.42M |
| Net Non-Operating Interest Income (Expense) | $1.37M | $1.37M | $1.49M | $8.35M | $1.71M |
| Non-Operating Interest Income | $1.37M | $1.37M | $1.49M | $8.35M | $1.71M |
| Special Income (Charges) | $0.00 | $258,000.00 | $414,000.00 | -$485,000.00 | $522,000.00 |
| -Less:Restructuring and Mergern & Acquisition | $0.00 | -$258,000.00 | -$414,000.00 | $499,000.00 | -$508,000.00 |
| Pretax Profit | -$11.06M | -$13.93M | -$11.74M | -$57.19M | -$13.18M |
| Net Profit | -$11.06M | -$13.93M | -$11.74M | -$57.19M | -$13.18M |
| Profit from Continuing Operations | -$11.06M | -$13.93M | -$11.74M | -$57.19M | -$13.18M |
| Net Income to Parent Company | -$11.06M | -$13.93M | -$11.74M | -$57.19M | -$13.18M |
| Net Income to Common Stockholders | -$11.06M | -$13.93M | -$11.74M | -$57.19M | -$13.18M |
| Basic EPS | -$0.06 | -$0.08 | -$0.07 | -$0.33 | -$0.07 |
| Diluted EPS | -$0.06 | -$0.08 | -$0.07 | -$0.33 | -$0.07 |
| Other Income (Expense) | – | $258,000.00 | $414,000.00 | -$485,000.00 | $522,000.00 |
| -Gain on Sale of Property/Plant/Equipment | – | – | – | $14,000.00 | $14,000.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $176.27M | $179.59M | $190.75M | $203.56M | $203.56M |
| Total Current Assets | $67.27M | $71.63M | $81.45M | $98.63M | $98.63M |
| Cash and Cash Equivalents & Short-Term Investments | $54.62M | $64.18M | $72.47M | $92.37M | $92.37M |
| -Cash and Cash Equivalents | $16.71M | $13.17M | $20.26M | $22.94M | $22.94M |
| -Short Term Investments | $37.91M | $51.01M | $52.21M | $69.43M | $69.43M |
| Receivables | $6.62M | $2.67M | $3.03M | $489,000.00 | $489,000.00 |
| -Accounts Receivable | $6.62M | $2.67M | $3.03M | $489,000.00 | $489,000.00 |
| Inventory | $742,000.00 | $1.16M | $1.92M | – | – |
| Other Current Assets | $5.29M | $3.62M | $4.03M | $4.60M | $4.60M |
| Total Non-Current Assets | $109.00M | $107.96M | $109.31M | $104.93M | $104.93M |
| Net PPE | $41.24M | $38.76M | $41.46M | $43.93M | $43.93M |
| -Gross PPE | $62.20M | $57.92M | $58.50M | $58.86M | $58.86M |
| -Accumulated Depreciation | -$20.96M | -$19.16M | -$17.04M | -$14.93M | -$14.93M |
| Investments and Advances | $66.74M | $68.21M | $66.86M | $59.99M | $59.99M |
| -Held to Maturity Securities | $66.74M | – | – | – | – |
| Other Non-Current Assets | $1.02M | $987,000.00 | $990,000.00 | $1.00M | $1.00M |
| Total Liabilities | $16.14M | $10.05M | $9.03M | $11.55M | $11.55M |
| Total Current Liabilities | $8.64M | $9.43M | $8.07M | $9.86M | $9.86M |
| Payables | $1.41M | $1.49M | $901,000.00 | $3.14M | $3.14M |
| -Accounts Payable | $1.41M | $1.49M | $901,000.00 | $3.14M | $3.14M |
| Current Accrued Expenses | $3.09M | $2.74M | $2.19M | $1.97M | $1.97M |
| Short-Term Debt and Capital Lease Obligation | $1.48M | $2.47M | $2.80M | $2.73M | $2.73M |
| -Current Capital Lease Obligation | $1.48M | $2.47M | $2.80M | $2.73M | $2.73M |
| Total Non-Current Liabilities | $7.51M | $618,000.00 | $953,000.00 | $1.69M | $1.69M |
| Long Term Debt and Capital Lease Obligation | $7.17M | $577,000.00 | $912,000.00 | $1.65M | $1.65M |
| -Long Term Capital Lease Obligation | $7.17M | $577,000.00 | $912,000.00 | $1.65M | $1.65M |
| Other Non-Current Liabilities | $341,000.00 | $41,000.00 | $41,000.00 | $41,000.00 | $41,000.00 |
| Total Equity | $160.13M | $169.54M | $181.72M | $192.01M | $192.01M |
| Stockholders' Equity | $160.13M | $169.54M | $181.72M | $192.01M | $192.01M |
| Capital Stock | $18,000.00 | $19,000.00 | $19,000.00 | $19,000.00 | $19,000.00 |
| -Common Stock | $18,000.00 | $19,000.00 | $19,000.00 | $19,000.00 | $19,000.00 |
| Additional Paid-In Capital | $403.84M | $416.32M | $414.57M | $413.12M | $413.12M |
| Retained Earnings | -$243.73M | -$232.67M | -$218.74M | -$207.00M | -$207.00M |
| Less: Treasury Stock | $0.00 | -$14.13M | -$14.13M | -$14.13M | -$14.13M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$10.46M | -$7.09M | -$12.73M | -$46.55M | -$11.86M |
| Net cash flow from continuing operations | -$10.46M | -$7.09M | -$12.73M | -$46.55M | -$11.86M |
| Net Income from Continuing Operations | -$11.06M | -$13.93M | -$11.74M | -$57.19M | -$13.18M |
| Gain/Loss from Continuing Operations | $0.00 | -$58,000.00 | -$414,000.00 | -$1.22M | -$524,000.00 |
| Depreciation & Depletion & Amortization | $1.80M | $2.12M | $2.11M | $5.96M | $1.89M |
| Other Non-Cash Items | $1.63M | $519,000.00 | $505,000.00 | $3.55M | $491,000.00 |
| Change in Working Capital | -$4.25M | $2.69M | -$4.39M | -$1.57M | -$1.65M |
| -Change in Receivables | -$3.95M | $353,000.00 | -$2.54M | $1.43M | $234,000.00 |
| -Change in Inventory | $420,000.00 | $757,000.00 | -$1.92M | – | – |
| -Change in Prepaid Assets | -$377,000.00 | $482,000.00 | $856,000.00 | $2.13M | -$347,000.00 |
| -Change in Payables and Accrued Expense | $218,000.00 | $1.77M | -$138,000.00 | -$2.71M | -$909,000.00 |
| -Change in Other Current Liabilities | -$564,000.00 | -$670,000.00 | -$656,000.00 | -$2.42M | -$625,000.00 |
| Net cash flow from investing | $14.36M | -$7,000.00 | $10.05M | $60.93M | $17.00M |
| Net Cash Flow from Continuing Investing Activities | $14.36M | -$7,000.00 | $10.05M | $60.93M | $17.00M |
| Net PPE Purchase and Sale | -$286,000.00 | $43,000.00 | -$276,000.00 | -$21.51M | -$695,000.00 |
| Net Investment Purchase and Sale | $14.64M | -$50,000.00 | $10.33M | $82.40M | $17.70M |
| Financing Cash Flow | -$356,000.00 | $1,000.00 | $0.00 | -$670,000.00 | -$82,000.00 |
| Net Cash Flow from Continuing Financing Activities | -$356,000.00 | $1,000.00 | $0.00 | -$670,000.00 | -$82,000.00 |
| Proceeds from Stock Option Exercised | $0.00 | – | – | $2,000.00 | $2,000.00 |
| Ending Cash Balance | $17.37M | $13.83M | $20.93M | $23.60M | $23.60M |
| Net Change in Cash | $3.54M | -$7.10M | -$2.68M | $13.71M | $5.06M |
| Beginning Cash Balance | $13.83M | $20.93M | $23.60M | $9.89M | $18.54M |
| Free Cash Flow | -$10.75M | -$7.30M | -$14.60M | -$70.29M | -$13.60M |
| Net Other Investing Changes | – | – | – | $41,000.00 | $0.00 |
| Net Common Stock Issuance | – | – | – | $0.00 | $0.00 |
| Net Other Financing Charges | – | – | – | -$672,000.00 | -$84,000.00 |
No comments yet — be the first to weigh in on HYLN.
Sign in to join the discussion.